Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DHRSX intronic transcript 1 (DHRSX-IT1) is annotated as a long non-coding RNA (lncRNA) gene; it is expressed as a non-protein-coding transcript derived from the intronic region of the DHRSX gene[1][5]. This RNA product does not encode a protein, and there is no evidence that it serves as a classical druggable target or is involved in well-established molecular pathways, disease processes, or pharmaceutical mechanisms. The molecular and functional characterization of DHRSX-IT1 remains lacking based on current, authoritative gene databases and literature[1][5]. Note: - DHRSX-IT1 is sometimes confused with the protein-coding gene DHRSX, which is an oxidoreductase enzyme involved in dolichol biosynthesis and the regulation of autophagy[2][3][4]. - The information above specifically refers to DHRSX-IT1, the lncRNA gene, not the protein-coding DHRSX. - There is no evidence to suggest that DHRSX-IT1 is a validated therapeutic target. Summary of status: - DHRSX-IT1 is a long non-coding RNA and not a recognized drug target. - The entry may be present due to confusion with the protein-coding DHRSX gene, or simply due to sparse or missing biological validation data[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DHRSX intronic transcript 1 (DHRSX-IT1).